Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2204, doi. 10.1038/onc.2013.176
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 17
Results: 13
1
2
PIK3CA and APC mutations are synergistic in the development of intestinal cancers.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2245, doi. 10.1038/onc.2013.167
- By:
- Publication type:
- Article
3
ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2179, doi. 10.1038/onc.2013.180
- By:
- Publication type:
- Article
4
Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2264, doi. 10.1038/onc.2013.157
- By:
- Publication type:
- Article
5
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2236, doi. 10.1038/onc.2013.168
- By:
- Publication type:
- Article
6
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2191, doi. 10.1038/onc.2013.177
- By:
- Publication type:
- Article
7
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2215, doi. 10.1038/onc.2013.172
- By:
- Publication type:
- Article
8
Control of gp130 expression by the mitogen-activated protein kinase ERK2.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2255, doi. 10.1038/onc.2013.159
- By:
- Publication type:
- Article
9
Translation factors and ribosomal proteins control tumor onset and progression: how?
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2145, doi. 10.1038/onc.2013.153
- By:
- Publication type:
- Article
10
ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2273, doi. 10.1038/onc.2013.174
- By:
- Publication type:
- Article
11
The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2157, doi. 10.1038/onc.2013.178
- By:
- Publication type:
- Article
12
The ribosomal protein S26 regulates p53 activity in response to DNA damage.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2225, doi. 10.1038/onc.2013.170
- By:
- Publication type:
- Article
13
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2169, doi. 10.1038/onc.2013.169
- By:
- Publication type:
- Article